Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
F A Tausk, … , R D Schreiber, I Gigli
F A Tausk, … , R D Schreiber, I Gigli
Published October 1, 1986
Citation Information: J Clin Invest. 1986;78(4):977-982. https://doi.org/10.1172/JCI112688.
View: Text | PDF
Research Article Article has an altmetric score of 3

Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.

  • Text
  • PDF
Abstract

We studied levels of erythrocyte C3b receptors (E-CR1) and correlated them to the level of circulating immune complexes (CIC) and complement activation in patients with or at risk for acquired immunodeficiency syndrome (AIDS). A significant reduction was found in patients with AIDS (185 +/- 93 CR1/cell), AIDS-related complex, and generalized lymphadenopathy, whereas healthy male homosexuals or normal controls had 434 +/- 193 and 509 +/- 140 CR1/cell, respectively (P less than 0.001). Family studies indicate that this defect is acquired. Reduction in E-CR1 was associated with increased levels of CIC when assayed by binding to Raji cells, but not when tested by C1q binding. Complement activation was assessed by levels of C3bi/C3d-g in plasma, measured with a monoclonal antibody specific for a neoantigen in C3d. AIDS patients had increased C3 activation (2.68 +/- 1.67%) when compared with normal controls (0.9 +/- 0.22%) (P less than 0.01). The decreased E-CR1, the presence of CIC, and C3 activation suggest that complement activation by immune complexes may play a role in the clinical expression of the disease.

Authors

F A Tausk, A McCutchan, P Spechko, R D Schreiber, I Gigli

×

Total citations by year

Year: 2022 2019 2014 2013 2012 2011 2009 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1969 Total
Citations: 1 1 1 1 1 2 1 4 1 3 1 1 3 1 6 4 3 5 4 7 4 7 13 11 4 4 5 3 1 103
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (103)

Title and authors Publication Year
Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
A Timofeeva, S Sedykh, G Nevinsky
Human vaccines 2022
HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy
C Kawakita, M Kinomura, N Otaka, M Kitagawa, H Sugiyama, N Kusano, M Mizuno, J Wada
Internal Medicine 2019
Antibody Fc
MA Lindorfer, J Köhl, RP Taylor
Antibody Fc 2014
Molecular and Cellular Mechanisms of Antibody Activity
F Nimmerjahn
2013
Complement receptor 1 (CR1) and Alzheimer's disease
H Crehan, P Holton, S Wray, J Pocock, R Guerreiro, J Hardy
Immunobiology 2012
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
Presence of p24-Antigen Associated to Erythrocyte in HIV-Positive Individuals Even in Patients with Undetectable Plasma Viral Load
MN Garcia, MS Farias, MM Ávila, RD Rabinovich, RJ Wilkinson
PloS one 2011
The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35)
D Liu, ZX Niu
Immunopharmacology and Immunotoxicology 2009
Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35)
CH Chen, I Ghiran, FJ Beurskens, G Weaver, JA Vincent, A Nicholson-Weller, LB Klickstein
Clinical & Experimental Immunology 2007
Humoral immunity to HIV-1: neutralization and beyond
M Huber, A Trkola
Journal of Internal Medicine 2007
Absence of erythrocyte-associated HIV-1 in vivo
DS Fierer, J Vargas, N Patel, G Clover
The Journal of Infectious Diseases 2007
Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria
AW Pawluczkowycz, MA Lindorfer, JN Waitumbi, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2007
HIV and complement: hijacking an immune defense
PK Datta, J Rappaport
Biomedicine & Pharmacotherapy 2006
Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome
FS Wang, FL Chu, L Jin, YG Li, Z Zhang, D Xu, M Shi, H Wu, JM Moulds
Clinical & Experimental Immunology 2005
Macrophages and HIV-1: dangerous liaisons
A Verani, G Gras, G Pancino
Molecular Immunology 2005
Processing of C3b-Opsonized Immune Complexes Bound to Non-Complement Receptor 1 (CR1) Sites on Red Cells: Phagocytosis, Transfer, and Associations with CR1
ML Craig, JN Waitumbi, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2005
The Pneumococcus
EI Tuomanen, TJ Mitchell, D Morrison, BG Spratt
2004
Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients
S Sadallah, C Hess, M Trendelenburg, C Vedeler, M Lopez-Trascasa, JA Schifferli
Clinical & Experimental Immunology 2003
Visualization of the Transfer Reaction: Tracking Immune Complexes from Erythrocyte Complement Receptor 1 to Macrophages
ML Craig, AJ Bankovich, RP Taylor
Clinical Immunology 2002
The Mechanism of Loss of CR1 during Maturation of Erythrocytes Is Different between Factor I Deficient Patients and Healthy Donors
S Miot, J Marfurt, E Lach-Trifilieff, C González-Rubio, M López-Trascasa, S Sadallah, JA Schifferli
Blood Cells, Molecules, and Diseases 2002
Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients
J E Teixeira, R Martinez, L M Câmara, J E Barbosa
Mycopathologia 2002
Bispecific Monoclonal Antibodies Mediate Binding of Dengue Virus to Erythrocytes in a Monkey Model of Passive Viremia
CS Hahn, OG French, P Foley, EN Martin, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2001
Clearance of anti-double-stranded DNA antibodies: The natural immune complex clearance mechanism
ML Craig, AJ Bankovich, JL McElhenny, RP Taylor
Arthritis & Rheumatism 2000
Promoter activity of the 5′ flanking region of the complement receptor type 1 (CR1) gene: basal and induced transcription
T Funkhouser
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2000
Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistantEnterococcus faecium
RM Rakita, VC Quan, K Jacques-Palaz, KV Singh, RC Arduino, M Mee, BE Murray
FEMS Immunology & Medical Microbiology 2000
Human Blood Groups
H Schenkel-Brunner
2000
A Soluble Recombinant Multimeric Anti-Rh(D) Single-Chain Fv/CR1 Molecule Restores the Immune Complex Binding Ability of CR1-Deficient Erythrocytes
S Oudin, MT Libyh, D Goossens, X Dervillez, F Philbert, B Réveil, F Bougy, T Tabary, P Rouger, D Klatzmann, JH Cohen
Journal of immunology (Baltimore, Md. : 1950) 2000
Transfer of Immune Complexes from Erythrocyte CR1 to Mouse Macrophages
ML Reinagel, RP Taylor
Journal of immunology (Baltimore, Md. : 1950) 2000
How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
A Nardin, MA Lindorfer, RP Taylor
Molecular Immunology 1999
Effect of Complement Consumption by Cobra Venom Factor on the Course of Primary Infection with Simian Immunodeficiency Virus in Rhesus Monkeys
JE Schmitz, MA Lifton, KA Reimann, DC Montefiori, L Shen, P Racz, K Tenner-Racz, MW Ollert, MA Forman, RS Gelman, CW Vogel, NL Letvin
AIDS Research and Human Retroviruses 1999
Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE)
I Csípö, E Kiss, P Soltész, P Antal-Szalmás, G Szegedi, JH Cohen, RP Taylor, M Kávai
Clinical & Experimental Immunology 1999
The Decade of Autoimmunity
BD Stollar
The Decade of Autoimmunity 1999
Mapping epitopes for 20 monoclonal antibodies to CR1
M Nickells, R Hauhart, M Krych, VB Subramanian, K Geoghegan-Barek, HC Marsh, JP Atkinson
Clinical & Experimental Immunology 1998
Modulation of integrin function inhibits HIV transmission to epithelial cells and fertilization
JB Davidson, GC Douglas
Journal of Reproductive Immunology 1998
Selective compartmental dominance: an explanation for a noninfectious, multifactorial etiology for acquired immune deficiency syndrome (AIDS), and a rationale for ozone therapy and other immune modulating therapies
F Shallenberger
Medical Hypotheses 1998
Invasive Pneumococcal Disease in the Immunocompromised Host
EN Janoff, JB Rubins
Microbial Drug Resistance 1997
Complement receptors in HIV infection
C Speth, L Kacani, MR Dierich
Immunological Reviews 1997
Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35) : vesiculation and/or proteolysis?
X Dervillez, S Oudin, MT Libyh, T Tabary, B Reveil, F Philbert, F Bougy, M Pluot, JH Cohen
Immunopharmacology 1997
The anti-inflammatory role of the erythrocyte: impairment in the elderly
H Gershon
Archives of Gerontology and Geriatrics 1997
Role of complement and Fc receptors in the pathogenesis of HIV-1 infection
DC Montefiori
Springer Seminars in Immunopathology 1997
Antigen/antibody content of circulating immune complexes in HIV-infected patients
M Stanojevic, S Zerjav, D Jevtovic, L Markovic
Biomedecine & Pharmacotherapy 1996
Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients
T Kanto, N Hayashi, T Takehara, K Katayama, M Kato, M Akiyama, A Kasahara, H Fusamoto, T Kamada
Journal of Medical Virology 1996
Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1
XX Peng, MA Wainberg, Y Tao, BG Brenner
Clinical and diagnostic laboratory immunology 1996
Symposium in Immunology V
MM Eibl, C Huber, HH Peter, U Wahn
1996
Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59
J Schmitz, JP Zimmer, B Kluxen, S Aries, M Bögel, I Gigli, H Schmitz
Journal of Clinical Investigation 1995
Primate Erythrocyte (E) Complement Receptor (CR1) as an Anchor Site for Bispecific-Based Therapies to Clear Pathogens or Autoantibodies Safely from the Circulation
RP Taylor, PJ Ferguson
Journal of Hematotherapy 1995
Natural Killer Suppressor Factors in Sera from HIV-Infected Subjects
MA Goicoa, L Sen, PS Iannitelli, RA Diez, ME Estevez
Scandinavian Journal of Immunology 1995
Reduced CD21 (CR2) and CD54 (ICAM-1) expression in MT2 cells with HIV-1 or HIV-2 strains
C Larcher, N Julen, WM Prodinger, M Tötsch, L Gürtler, MP Dierich
Immunology Letters 1995
Circulating levels of mannose binding protein in human immunodeficiency virus infection
G Senaldi, ET Davies, M Mahalingam, J Lu, A Pozniak, M Peakman, KB Reid, D Vergani
Journal of Infection 1995
Review: Bacterial endotoxin and the human monoclonal antibody HA-IA: specificity, potential mechanisms of action, and limits to its effectiveness
PH Lagrange, HS Blanchard, A Felten
Journal of Endotoxin Research 1995
Human Blood Groups: Chemical and Biochemical Basis of Antigen Specificity
H Schenkel-Brunner
1995
Differential susceptibility of immune complexes to release from the erythrocyte CR1 receptor by factor I
I Yokoyama, F Waxman
Molecular Immunology 1994
Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro
S Shapiro, D Kohn, B Miller, H Gershon
Clinical & Experimental Immunology 1994
Proteolytic cleavage of CR1 on human erythrocytesin vivo: evidence for enhanced cleavage in AIDS
M Pascual, C Danielsson, G Steiger, JA Schifferli
European Journal of Immunology 1994
Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.
Shapiro S, Kohn D, Miller B, Gershon H
Clinical & Experimental Immunology 1994
Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation
CJ Reist, MJ Combs, BY Croft, RP Taylor
European Journal of Immunology 1993
Immunopathogenesis of HIV Infection
AS Fauci
Annals of the New York Academy of Sciences 1993
Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge
SS Tan, EM O'Toole, CB Kurtz, JH Weis
Immunology 1993
Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21)
DC Montefiori, K Stewart, JM Ahearn, J Zhou, J Zhou
Journal of virology 1993
Complement enhancement of HIV infection is mediated by complement receptors
N Thieblemont, C Delibrias, E Fischer, L Weiss, MD Kazatchkine, N Haeffner-Cavaillon
Immunopharmacology 1993
Anti-lymphocyte natibodies and circulating immune complexes in the sera of patients with myelopathy associated with human T lymphotropic virus type_I
K Shimada, CS Koh, N Yanagisawa, N Tsukada, M Osame
Journal of Neuroimmunology 1993
Progress in Immunology Vol. VIII
J Gergely, M Benczúr, A Erdei, A Falus, G Füst, G Medgyesi, G Petrányi, É Rajnavölgyi
1993
Expression and localization of proteins of the complement system in human skin
N Dovezenski, R Billetta, I Gigli
Journal of Clinical Investigation 1992
Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system
JC Edberg, RP Kimberly, RP Taylor
European Journal of Immunology 1992
Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1 receptor
Y Izumi, W Frank
Molecular Immunology 1992
Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?
PE Ruuska, I Ikäheimo, S Silvennoinen-Kassinen, ML Käär, A Tiilikainen
Clinical & Experimental Immunology 1992
Complement Receptor 1 (CR1) Expression in Chronic Myeloid Leukemia
F Lanza, G Castoldi
Leukemia & Lymphoma 1992
CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody
DC Montefiori, J Zhou, DI Shaff
Clinical & Experimental Immunology 1992
Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia
S Karpatkin, MA Nardi, YH Kouri
Proceedings of the National Academy of Sciences 1992
Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons
RA June, AL Landay, K Stefanik, TF Lint, GT Spear
Immunology 1992
Distribution and quantitative expression of the complement receptor type 1 (CR1) on human peripheral blood T lymphocytes
DD Yaskanin, LF Thompson, FJ Waxman
Cellular Immunology 1992
The systemic lupus erythematosus patient and transfusion medicine
ST Nance
Transfusion Science 1992
Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes
LA Hebert, DJ Birmingham, XP Shen, FG Cosio
Clinical Immunology and Immunopathology 1992
Membrane Defenses Against Attack by Complement and Perforins
CJ Parker
1992
CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody.
Montefiori DC, Zhou J, Shaff DI
Clinical & Experimental Immunology 1992
Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1)
N Madi, JP Paccaud, G Steiger, JA Schifferli
Clinical & Experimental Immunology 1991
The Complement System in HIV Disease
G Füst, E Ujhelyi, T Hidvégi, K Pálóczi, R Mihalik, S Hollán, K Nagy, M Kirschfink
Immunological Investigations 1991
Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment
RP Taylor, WM Sutherland, CJ Reist, DJ Webb, EL Wright, RH Labuguen
Proceedings of the National Academy of Sciences 1991
Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis
GT Spear, BL Sullivan, DM Takefman, AL Landay, TF Lint
Immunology 1991
Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion
P Cornillet, F Philbert, MD Kazatchkine, JH Cohen
Journal of Immunological Methods 1991
7 Complement
KA Davies
Baillière's Clinical Haematology 1991
The complement system in HIV infection
GT Spear
Clinical Immunology Newsletter 1991
The Clearance of Immune Complexes From the Circulation of Man and Other Primates
LA Hebert
American Journal of Kidney Diseases 1991
The Immunopathogenesis of AIDS
JR Baker, T Leigh
Dermatologic Clinics 1991
Immunology of Renal Disease
CD Pusey
1991
Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N, Paccaud JP, Steiger G, Schifferli JA
Clinical & Experimental Immunology 1991
The Human C3b Receptor: Function and Role in Human Diseases
F Tausk, I Gigli
Journal of Investigative Dermatology 1990
Quantification of Complement Receptor 1 on Erythrocytes: Follow-Up of HIV-1-Infected Patients with AIDS-Related Complex/Walter-Reed 5 under Treatment with Intravenous Immunoglobulin
MO Spycher, PJ Späth
Vox Sanguinis 1990
The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus
F Tausk, E Harpster, I Gigli
Arthritis & Rheumatism 1990
Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis
GT Spear, BL Sullivan, AL Landay, TF Lint
Journal of virology 1990
Physiological and pathological aspects of circulating immune complexes
JA Schifferli, RP Taylor
Kidney International 1989
Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome
A Hammond, AC Rudge, S Loizou, SJ Bowcock, MJ Walport
Arthritis & Rheumatism 1989
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?
M Peakman, G Senaldi, D Vergani
Journal of clinical pathology 1989
Immune Complex Assays: Diagnostic and Clinical Application
TM Phillips, FA Salinas
Critical Reviews in Clinical Laboratory Sciences 1989
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases
MJ Walport, PJ Lachmann
Arthritis & Rheumatism 1988
Antibody-dependent enhancement of viral infectivity: II. Potential significance in aids
WE Robinson, DC Montefiori, WM Mitchell
Infectious Diseases Newsletter 1988
Renal Complications of Acquired Immunodeficiency Syndrome in Children
E Rousseau, P Russo, N Lapointe, S O'Regan
American Journal of Kidney Diseases 1988
Autoimmune Manifestations of Human Immunodeficiency Virus (HIV) Infection
LH Calabrese
Clinics in Laboratory Medicine 1988
Immunodeficiency and Disease
AD Webster
1988
Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome
BS Bender, JF Bohnsack, SH Sourlis, MM Frank, TC Quinn
Journal of Clinical Investigation 1987
Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface
M Walport, YC Ng, PJ Lachmann
Clinical & Experimental Immunology 1987
Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry
JH Cohen, JP Aubry, MH Jouvin, J Wijdenes, J Bancherau, M Kazatchkine, JP Revillard
Journal of Immunological Methods 1987
Protides of the Biological Fluids
PA Small, RH Waldman
Protides of the Biological Fluids 1969

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
15 readers on Mendeley
See more details